TrialClinical lymphoma, myeloma & leukemia2021

A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia.

Matthew C Cheung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.